多基因风险评分在临床高危人群精神病预测中的作用
该研究纳入764名临床高危个体和279名未患病个体,随访2年,评估多基因风险评分(PRS)对精神病转化的预测价值。结果显示,在欧洲裔中PRS可区分转化者与非转化者,并小幅提升风险计算器的个体化预测;但在非欧洲裔中区分能力不显著、预测效能有限。
要点
- 在欧洲裔高危人群中,精神病转化者的PRS显著高于非转化者和未患病者;非转化者与未患病者相近。
- 将PRS加入已验证的精神病风险计算器可小幅改善个体化预测,其信息贡献低于思维紊乱严重度。
- 非欧洲裔中转化者与非转化者的PRS差异不显著,提示PRS跨 ancestry 适用性有限。
核心结论
- PRS可区分精神病转化者与非转化者,并在加入风险计算器后小幅改善个体化精神病风险预测。
- 精神分裂症PRS在高危人群风险预测中有前景,但其潜在效用受非欧洲裔人群表现不佳的限制。
研究设计与样本
- 研究纳入符合精神病高危研究标准的个体764名和未患病个体279名,随访至2年。
- PRS基于最新的精神分裂症和双相障碍全基因组关联研究构建。
- 精神病风险计算器变量包括应激生活事件、创伤、思维内容紊乱、言语学习、信息处理速度和精神病家族史。
主要发现
- 欧洲裔中PRS按组别差异显著,转化者高于非转化者和未患病者,非转化者与未患病者相似。
- 非欧洲裔中PRS按组别差异显著,转化者与非转化者差异不显著,但转化者显著高于未患病者,非转化者与未患病者无差异。
- 欧洲裔的R2liability(按研究人群疾病风险率调整的R2,此处假设2年精神病风险为10%至30%)在9.2%至12.3%之间,非欧洲裔在3.5%至4.8%之间。
- PRS加入风险计算器所贡献的风险预测信息量小于思维紊乱严重度,与其它变量相似或更大。
- 欧洲裔中PRS与风险计算器的信息处理速度和言语记忆变量相关。
关键数值与推荐
- 符合研究标准的高危综合征个体2年精神病风险约为15%至25%。
- R2liability假设的2年精神病风险范围为10%至30%。
临床怎么用
- 在高危人群中可考虑将PRS作为风险计算器的补充信息,但需注意其增量预测价值有限。
- PRS当前不适用于非欧洲裔人群的个体化精神病风险预测,临床解读应谨慎。
局限性
- PRS在非欧洲裔人群中表现不佳,限制了其跨人群的潜在效用。
- PRS加入风险计算器所贡献的预测信息量小于思维紊乱严重度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The 2-year risk of psychosis in persons who meet research criteria for a high-risk syndrome is about 15%-25%; improvements in risk prediction accuracy would benefit the development and implementation of preventive interventions. The authors sought to assess polygenic risk score (PRS) prediction of subsequent psychosis in persons at high risk and to determine the impact of adding the PRS to a previously validated psychosis risk calculator. METHODS: Persons meeting research criteria for psychosis high risk (N=764) and unaffected individuals (N=279) were followed for up to 2 years. The PRS was based on the latest schizophrenia and bipolar genome-wide association studies. Variables in the psychosis risk calculator included stressful life events, trauma, disordered thought content, verbal learning, information processing speed, and family history of psychosis. RESULTS: For Europeans, the PRS varied significantly by group and was higher in the psychosis converter group compared with both the nonconverter and unaffected groups, but was similar for the nonconverter group compared with the unaffected group. For non-Europeans, the PRS varied significantly by group; the difference between the converters and nonconverters was not significant, but the PRS was significantly higher in converters than in unaffected individuals, and it did not differ between nonconverters and unaffected individuals. The R2liability (R2 adjusted for the rate of disease risk in the population being studied, here assuming a 2-year psychosis risk between 10% and 30%) for Europeans varied between 9.2% and 12.3% and for non-Europeans between 3.5% and 4.8%. The amount of risk prediction information contributed by the addition of the PRS to the risk calculator was less than severity of disordered thoughts and similar to or greater than for other variables. For Europeans, the PRS was correlated with risk calculator variables of information processing speed and verbal memory. CONCLUSIONS: The PRS discriminates psychosis converters from nonconverters and modestly improves individualized psychosis risk prediction when added to a psychosis risk calculator. The schizophrenia PRS shows promise in enhancing risk prediction in persons at high risk for psychosis, although its potential utility is limited by poor performance in persons of non-European ancestry.
引用
- Perkins DO, Olde Loohuis L, Barbee J, et al. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. Am J Psychiatry. 2019. PMID: 31711302. doi:10.1176/appi.ajp.2019.18060721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。